Search research articles
Contact Us
Filters
Showing results (301-310 of 333) with videos related to
Page
of 34
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group
H-J Schmoll, C Kollmannsberger, B Metzner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
J Oldenburg, D M Berney, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
C Kollmannsberger, W Budach, M Stahl, et al.
Leukemia
|
March 8, 2014
A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells
M Braig, N Pällmann, M Preukschas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
R Mesía, F Rivera, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
M Aapro, Y Beguin, C Bokemeyer, et al.
Oncology
|
March 1, 1997
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic colorectal cancer
C H Köhne, H Wilke, W Hiddemann, et al.
ESMO Open
|
May 14, 2024
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis
C Seidel, C Schaefers, E A Connolly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
M Aapro, Y Beguin, C Bokemeyer, et al.
British Journal of Cancer
|
September 11, 2008
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
J Panse, K Friedrichs, A Marx, et al.
Page
of 34
Search research articles
Search
Showing results (301-310 of 333) with videos related to
Sort By:
Page
of 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 22, 2003
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group
H-J Schmoll, C Kollmannsberger, B Metzner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 22, 2022
Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
J Oldenburg, D M Berney, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 28, 2005
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
C Kollmannsberger, W Budach, M Stahl, et al.
Leukemia
|
March 8, 2014
A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells
M Braig, N Pällmann, M Preukschas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 26, 2010
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck
R Mesía, F Rivera, A Kawecki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 23, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
M Aapro, Y Beguin, C Bokemeyer, et al.
Oncology
|
March 1, 1997
Phase II evaluation of 5-fluourouracil plus folinic acid and alpha 2b-interferon in metastatic colorectal cancer
C H Köhne, H Wilke, W Hiddemann, et al.
ESMO Open
|
May 14, 2024
Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis
C Seidel, C Schaefers, E A Connolly, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2018
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
M Aapro, Y Beguin, C Bokemeyer, et al.
British Journal of Cancer
|
September 11, 2008
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
J Panse, K Friedrichs, A Marx, et al.
Page
of 34